“When treating cancer, personalization is critical. By teaming with Philips, we can provide an umbrella of guidance and trust from Dana-Farber to other locations and institutions around the country and around the world where patients receive care,” said David Jackman, MD, Medical Director for Clinical Pathways at the Dana-Farber Cancer Institute. “Since 85% of cancer care happens in community hospitals, providing access to information and guidance is helpful to an oncologist outside of our Dana-Farber network, and valuable for patients, since they know they are getting input from a world-class facility.”
Philips Oncology Solutions spotlight at ASCO
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Philips will focus on three key areas featuring Detection and Monitoring; Precision Diagnostics; and Therapy Decision-Support. Visitors will experience intelligent, integrated oncology solutions to support and enhance:
•Diagnosis, staging, and tumor progression tracking
•Biological tumor characterization
•Molecular and Multidisciplinary Tumor Board collaboration
•Patient stratification, therapy prioritization, selection and trial matching
•Radiation therapy simulation, planning and workflow management
In booth #2122 at ASCO, Philips will showcase key solutions across its oncology portfolio including:
•Oncology Pathways – high-quality, detailed, evidence-based oncology treatment protocols powered by Dana-Farber, allows clinical users to navigate through the branches of the pathways to make clinical decisions and provide treatment plan recommendations, including clinical trials.
•Oncology Platform [3] – comprehensive platform integrates data from hospital information systems across different clinical domains including radiology, pathology, and genomics, to enable a detailed view of the patient and care path to facilitate cross-disciplinary collaboration and communication.
•Pathology – Philips IntelliSite Pathology Solution is the first and only digital pathology solution in the U.S. to be marketed for primary diagnostic use to reduce pressure on pathology services by streamlining workflows and extending collaboration to help increase diagnostic confidence.
•Genomics [4] – end-to-end precision medicine platform automates pathologists’ workflows through collaboration with oncologists and peers, enabling genomic interpretation based on a single, comprehensive patient view, which also includes OncoSignal [5], signaling pathway activity analysis to reveal tumor-driving mechanisms.
